CN105998271A - Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease - Google Patents

Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease Download PDF

Info

Publication number
CN105998271A
CN105998271A CN201610523545.XA CN201610523545A CN105998271A CN 105998271 A CN105998271 A CN 105998271A CN 201610523545 A CN201610523545 A CN 201610523545A CN 105998271 A CN105998271 A CN 105998271A
Authority
CN
China
Prior art keywords
parts
chinese medicine
heat
syndrome
intrinsic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610523545.XA
Other languages
Chinese (zh)
Inventor
孙世林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201610523545.XA priority Critical patent/CN105998271A/en
Publication of CN105998271A publication Critical patent/CN105998271A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A61K36/634—Forsythia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538—Schizonepeta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease. The traditional Chinese medicine is characterized by being prepared from, by weight, 30-35 parts of fructus forsythiae, 20-25 parts of cape jasmine, 20-22 parts of cortex mori radicis, 30-32 parts of astragalus membranaceus, 15-18 parts of indigo naturalis, 20-25 parts of roots of common peony, 15-20 parts of licorice roots, 15-18 parts of great burdock achene, 10-12 parts of platycodon grandiflorum and 8-10 parts of fineleaf schizonepeta herbs. According to the traditional Chinese medicine, the various raw materials are organically combined, all ingredients are coordinated and interact with each other, both symptoms and root causes of lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease can be treated, the effect is good, and the lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease is fundamentally treated. For years, tracking investigation and statistics of 100 patients show that the effective rate of the prescription is 100%, the effect showing rate is 99%, and the curing rate is 94%.

Description

A kind of Chinese medicine treating lung meridian intrinsic heat pattern of syndrome nasal eczema disease
Present disclosure relates to a kind of Chinese medicine, a kind of Chinese medicine treating lung meridian intrinsic heat pattern of syndrome nasal eczema disease.
Background technology nasal eczema sick with red swelling of the skin, erosion near anterior nares, form a scab, burn and itch, prolonged do not heal, recurrent exerbation Common cacorhinia for feature.How to be have intrinsic heat by lung meridian, multiple by wind-heat evil toxin, or because eating and drinking without temperance taste are lacked of proper care, retention and fumigation of damp-heat inside the body Form.What the present invention mainly studied is that one of clinical common pattern of syndrome lung meridian intrinsic heat pattern of syndrome nasal eczema is sick, and this pattern of syndrome system is because of lung Through have intrinsic heat, part of the body cavity above the diaphragm housing the heart and lungs accumulated heat, attack nose key and gather and do not dissipate caused.Lung meridian intrinsic heat, the stasis of blood is stagnant in nose, skin at smoked nostril of burning, then go out The existing granular hillock of foxtail millet, micro-red, continue the shallow erosion in table, overflows yellow fat water, or knot yellow crusts；Intenseness of heat then swells and pain, anterior nares skin Scorching hot dry, pain of itching of having a stuffy nose；The raw skin ulcer of the company's of being often accompanied by lip, tears are many and yellow, and vibrissa comes off, brothers' hectic fever, headache, constipation of generating heat, tongue The symptoms such as matter is red, yellow fur, rapid pulse.At present, this disease of western medical treatment is taked to take antibiotic or the mode of sulfanilamide anti-inflammation drugs more, controls Mark does not effects a permanent cure, and side effect is very big.
Summary of the invention it is an object of the invention to the Therapeutic Principle according to " clearing heat and purging lung, subduing swelling and detoxicating ", it is provided that Yi Zhongneng The Chinese medicine that treatment lung meridian intrinsic heat pattern of syndrome nasal eczema is sick, uses this Chinese medicine not only to cure speed soon, can not be relapsed after the healing, it is possible to reach mark This double effect controlled, and without any side effects, also have good opsonic action to healthy.
For realizing the above-mentioned purpose of the present invention, it is sick that the technical scheme is that one treats lung meridian intrinsic heat pattern of syndrome nasal eczema Chinese medicine, it is characterized in that the Chinese medicine preparation being made up of the medical material of following weight proportion: Fructus Forsythiae 30--35 part, Fructus Gardeniae 20--25 part, Cortex Mori 20-22 part, Radix Astragali 30--32 part, Indigo Naturalis 15 18 parts, Radix Paeoniae Rubra 20--25 part, 15 20 parts of Radix Glycyrrhizae, Fructus Arctii 15-- 18 parts, Radix Platycodonis 10--12 part, Herba Schizonepetae 8--10 part.The processing technique of the present invention is: various medical material grindings become end, then with often Rule method " whole part " is extracted and is made instant Chinese medicine granule, carries out subpackage according to every pouch 10 grams, airtight, in place shady and cool, dry Preserve.Dissolving with boiled water after meal and take, having part insoluble matter is normal phenomenon, and under all taking after mixing, twice on the one (the most each Once), each one bag, 7 days be a course for the treatment of.Take medicine period, avoid pungent food and process and raw meat meat or fish stimulating food, can not because of itch or form a scab and Digging nose with finger, have incrustation person to treat its autospasy, in order to avoid increasing the weight of the state of an illness to extend the course of disease, the work and rest keeping good is accustomed to, and association closes Reason decompression, actively participates in outdoor activity, loosens mood, avoid staying up late as far as possible.
Fructus Forsythiae of the present invention has heat-clearing and toxic substances removing, dispelling wind and heat pathogens, dispersing swelling and dissipating binds, the effect of the diuresis that clears away heart-fire；Use Fructus Gardeniae there is effect of pathogenic fire purging relieving restlessness, clearing away heat-damp and promoting diuresis, removing pathogenic heat from blood and toxic substance from the body, reducing swelling and alleviating pain；Use Cortex Mori have eliminating pathogen from the lung for relieving asthma, Inducing diuresis to remove edema, effect of purte the white；The Radix Astragali used has tonifying Qi and lifting yang, benefit defends consolidating superficial resistance, inducing diuresis to remove edema, the merit of torr skin ulcer granulation promoting Effect；The Indigo Naturalis used has effect of heat-clearing and toxic substances removing, blood cooling and ecchymoses removing, purging liver-fire, dispelling wind and relieving convulsion；The Radix Paeoniae Rubra used has heat clearing away Removing heat from blood, YIN nourishing and the production of body fluid promoting, eliminating fire and detoxication, effect of eliminating stasis to stop pain；The Radix Glycyrrhizae used only has QI invigorating invigorating middle warmer, relieving spasm to stop pain, lung moistening Cough, effect of coordinating the actions of various ingredients in a prescription；The Fructus Arctii used has dispelling wind and heat pathogens, rash sore-throat relieving, scattered swollen, the effect of sliding profit relieving constipation of removing toxic substances； The Radix Platycodonis used has effect of dispersing lung-QI and dissipating phlegm, sore-throat relieving, evacuation of pus；The Herba Schizonepetae used have deliver scattered wind, rash disappears skin ulcer, parch to black only Effect of blood.Any of the above raw material is organically combined by the present invention, mutually coordinated between each composition, interacts, right The enough treating both the principal and secondary aspects of a disease of lung meridian intrinsic heat pattern of syndrome nasal eczema condition of disease, respond well, fundamentally treat this disease.For many years, by 100 examples The follow-up investigation statistics of this type of patient, shows that this prescription effective percentage reaches 100%, and obvious effective rate reaches 99%, and cure rate reaches 94%.
Below by the basic condition analysis about data, further illustrate the effect of the present invention.
Table one: general patient demographic's structure situation
Table two: curative effect situation
Enumerate three model cases below and further illustrate the effect of the present invention:
1, Jiang, female, nineteen ninety birth, from the beginning of 20 years old, red swelling of the skin near anterior nares, erosion, incrustation occur, repeatedly sends out Make, and come off with vibrissa, red tongue, yellow fur, the symptom such as rapid pulse.After half a year, it is diagnosed as lung meridian intrinsic heat pattern of syndrome nasal eczema in here Sick.After taking 1 course for the treatment of of this prescription, symptom has been alleviated, and after 2 courses for the treatment of, symptom substantially alleviates, and after 3 courses for the treatment of, symptom disappears entirely, Recovery from illness.
2, Lee, female, birth in 1979,32 years old starts, and occurs that anterior nares skin burns is dry and lifts, micro-hypodynia symptom of itching, warp The symptoms such as not healing for a long time, and many and yellow with tears, skin is dried-up, brothers' hectic fever, red tongue with yellow fur rapid pulse.After 1 year, it is diagnosed as in here Lung meridian intrinsic heat pattern of syndrome nasal eczema is sick.After taking 1 course for the treatment of of this prescription, remission, after 2 courses for the treatment of, symptom is substantially alleviated, after connect again Continuing and take 2 courses for the treatment of, symptom disappears entirely, recovery from illness.、
3, grandson, man, calendar year 2001 birth, 9 years old starts, and occurs that near anterior nares, the granular hillock of foxtail millet occurs in skin, and micro-red, nasal obstruction is itched Pain shape, and with the raw skin ulcer of even lip, constipation of generating heat, headache, red tongue, yellow fur, the symptom such as rapid pulse.After 1 month, diagnose in here Sick for lung meridian intrinsic heat pattern of syndrome nasal eczema.After taking 1 course for the treatment of of this prescription, symptom is the most basic to disappear, after take again and carry out 1 course for the treatment of After treatment, recovery from illness.
The present invention, for describing the present invention in detail, is done the most in detail by detailed description of the invention below in conjunction with specific embodiment Description.
Embodiment 1: Fructus Forsythiae 30 grams, Fructus Gardeniae 20 grams, Cortex Mori 20 grams, the Radix Astragali 30 grams, Indigo Naturalis 15 grams, Radix Paeoniae Rubra 20 grams, Radix Glycyrrhizae 15 grams, Fructus Arctii 15 grams, Radix Platycodonis 10 grams, Herba Schizonepetae 8 grams.Any of the above medical material grinding is become end, then " entirely becomes by conventional method Point " extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.
Embodiment 2: Fructus Forsythiae 32 grams, Fructus Gardeniae 22 grams, Cortex Mori 21 grams, the Radix Astragali 31 grams, Indigo Naturalis 16 grams, Radix Paeoniae Rubra 22 grams, Radix Glycyrrhizae 18 grams, Fructus Arctii 16 grams, Radix Platycodonis 11 grams, Herba Schizonepetae 9 grams.Any of the above medical material grinding is become end, then " entirely becomes by conventional method Point " extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.
Embodiment 3: Fructus Forsythiae 35 grams, Fructus Gardeniae 25 grams, Cortex Mori 22 grams, the Radix Astragali 32 grams, Indigo Naturalis 18 grams, Radix Paeoniae Rubra 25 grams, Radix Glycyrrhizae 20 grams, Fructus Arctii 18 grams, Radix Platycodonis 12 grams, Herba Schizonepetae 10 grams.Any of the above medical material grinding is become end, then " entirely becomes by conventional method Point " extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, the place of being dried.

Claims (1)

1. treat the Chinese medicine that lung meridian intrinsic heat pattern of syndrome nasal eczema is sick, it is characterized in that the Chinese medicine being made up of the medical material of following weight proportion Preparation: Fructus Forsythiae 30--35 part, Fructus Gardeniae 20--25 part, Cortex Mori 20-22 part, Radix Astragali 30--32 part, Indigo Naturalis 15 18 parts, Radix Paeoniae Rubra 20--25 part, 15 20 parts of Radix Glycyrrhizae, Fructus Arctii 15--18 part, Radix Platycodonis 10--12 part, Herba Schizonepetae 8--10 part.
CN201610523545.XA 2016-07-06 2016-07-06 Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease Pending CN105998271A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610523545.XA CN105998271A (en) 2016-07-06 2016-07-06 Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610523545.XA CN105998271A (en) 2016-07-06 2016-07-06 Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease

Publications (1)

Publication Number Publication Date
CN105998271A true CN105998271A (en) 2016-10-12

Family

ID=57107101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610523545.XA Pending CN105998271A (en) 2016-07-06 2016-07-06 Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease

Country Status (1)

Country Link
CN (1) CN105998271A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王永钦: "《中以耳鼻咽喉口腔科学》", 31 October 2001 *

Similar Documents

Publication Publication Date Title
CN105194508A (en) Traditional Chinese medicine for treating chronic gastritis
CN103536889B (en) One is treated senile chronic tracheitis and is merged emophysematous Chinese medicine decoction
CN105168759A (en) Traditional Chinese medicine for health maintenance, prevention and treatment of respiratory system diseases
CN103536881A (en) Drug for treating chronic gastritis
CN102302733B (en) Oral Chinese medicinal composition for treating ovarian cyst
CN103099882B (en) Traditional Chinese medicine composition for treating liver qi-stagnation type hyperplasia of mammary glands
CN105012833A (en) Traditional Chinese medicine for treating polyneuropathy
CN104971331A (en) Orally-taken externally-applied traditional Chinese medicine composition for treating proliferation of mammary gland and preparation method
CN104784346A (en) Pruritus treating traditional Chinese medicine lotion preparation method
CN103520668A (en) Traditional Chinese medicine for treating heart and qi deficiency symptom type chest stuffiness and pains
CN103610934B (en) A kind of Chinese medicine for the treatment of pharyngitis
CN103520673B (en) Traditional Chinese medicine for treating deficiency of Qi and blood syndrome type of menopathy
CN105412877A (en) Traditional Chinese medicine preparation for treating influenza and preparation method thereof
CN104367827A (en) Traditional Chinese medicine for treating spleen-qi deficiency-weakness syndrome type somnolence
CN104306575A (en) Traditional Chinese medicine for treating qi stagnation type abdominal mass
CN104107344A (en) Traditional Chinese medicine composition for treating chronic bronchitis
CN104758668A (en) Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat
CN104606395A (en) Traditional Chinese medicine prescription treating menstrual fever
CN105998271A (en) Traditional Chinese medicine for treating lung-meridian-intrinsic-heat-syndrome-type nasal eczema disease
CN103520693B (en) Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris
CN103550662B (en) Traditional Chinese medicine for treating liver and stomach incoordination type distention and fullness
CN107638465A (en) A kind of Chinese medicine composition for treating arthralgia and preparation method thereof
CN105343364A (en) Traditional Chinese medicine for treating fire toxin accumulation syndrome type palate carbunculosis
CN103585511B (en) A kind of Chinese medicine for the treatment of liver depression type pyrexia
CN104547446B (en) A kind of Chinese medicine for the treatment of qi-deficiency type abdominal postoperative urine retention

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161012